LEF1 and chronic myelogenous leukemia, BCR-ABL1 positive: We propose that Bcr-Abl provides proliferative advantages in CML cells by misregulating the translation of LEF1, and we further propose that this misregulation extends to the general class of mRNAs that contain IRESs.